High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

Affiliations

• ¹ Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome;.
• ² Department of Hematology, Pugliese Ciaccio Hospital, Catanzaro.
• ³ Italian Group for Adult Hematologic Diseases (GIMEMA) Foundation, Rome.
• ⁴ Department of Hematology, Arcispedale S. Maria Nuova, Reggio Emilia.
• ⁵ Hematology, A.O.U. Città della Salute e della Scienza di Torino.
• ⁶ SC Ematologia, Azienda Sanitaria Universitaria Integrata, Trieste.
• ⁷ Ematologia e Centro Trapianti. IRCCS Ospedale Policlinico San Martino, Genova.
• ⁸ Cattedra di Ematologia, CTMO University, Parma.
• ⁹ Department of Onco-Hematology, University of Perugia, Santa Maria Hospital, Terni.
• ¹⁰ Department of Hematology, Niguarda Ca Granda Hospital, Milan.
• ¹¹ Hematology Department, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan.
• ¹² Department of Hematology, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria.
• ¹³ Hematology, Department of Medical Science Surgery and Neurosciences, University of Siena.
• ¹⁴ Department of Hematology, S. Camillo Hospital, Rome.
• ¹⁵ Hematology, Department di Biomedicina e Prevenzione, Tor Vergata University, Rome.
• ¹⁶ Department of Hematology, University of Messina.
• ¹⁷ Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome.
• ¹⁸ Department of Emergency and Transplantation, Hematology Section, University of Bari.
• ¹⁹ Department of Hematology, S. Anna Hospital, Ferrara, Italy.